Dr. med. Vesile Schneider

Fachärztin für Innere Medizin. Hausärztin in Friedrichshafen, Ehlersstraße 19.

Publikationen

• Schneider V, Rischke HC, Drevs J: Chapter „Angiogenesis“ in: The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies (Medical Radiology / Radiation Oncology), M. Molls, AJ Giaccia, C. Nieder, MS Anscher (Hrsg.). Springer, Berlin, 2009.
• Trarbach T, Drevs J, Strumberg D, Gauler TC, Schneider V, Eberhardt WE, Marotti M, Puchalski TA, Swaisland AJ: A phase I, open-label, multicenter study of cediranib and AZD0530 in patients with advanced solid tumors. J Clin Oncol 26, 2008 (May 20 suppl; abstr 3592).
• Schneider V: Bildgebung der Tumorangiogenese. Kapitel in: Tumorangiogenese, Grundlagen und therapeutische Ansätze. Uni-Med Bremen, 2007.
• Schneider V, Drevs J: The use of vascular biomarkers and imaging studies in the early clinical development of antitumor agents targeting angiogenesis. J Intern Med 2006 Dec; 260(6): 517-29. Review.
• Ding XQ, Dolu V, Hadac EM, Schuetz M, Miller LJ: Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor. Receptors Channels 2003; 9(2): 83-91.
• Ding XQ, Dolu V, Hadac EM, Holicky EL, Pinon DI, Lybrand TP, Miller LJ: Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal sample. J Biol Chem 2001 Feb 9; 276(6): 4236-44.
• Holtmann MH, Ganguli S, Hadac EM, Dolu V, Miller LJ: Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem 1996 Jun 21; 271(25): 14944-9.